Alphabetical search
A| B| C| D| E| F| G| H| I| J| K| L| M| N| O| P| Q| R| S| T| U| V| W| X| Y| Z
Search by Name or Code Test
(Para exportar a PDF debe añadir la ténica a Mi Lista y lickar en Ver Mi lista, selección máxima 25 técnicas)
7
MYELOID PANEL, BONE MARROW
Method:
Microscopic observation.
Mounting:
Delivery period:3
Sample:
5 mL Hematological extension Tripotassium EDTA (2-8 ºC - Refrigerate)
Transport:
Use a slide carrier box.
Reference V.:
Mielograma:
Reported for each case
162
METHEMOGLOBIN, BLOOD
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:3
Sample:
5 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)
BLV:

End of workday (Methemoglobin Inducers) < 1.50 %
End of workday (Nitrobenzene) < 1.50 %
Reference V.:

Unexposed personnel < 1.00 %
Review:
21/11/2010
909
MIA (MELANOMA INHIBITORY ACTIVITY, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:32
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 12.00 ug/L * 1.0 = ng/mL
973
MEXILETINE, SERUM
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:8
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Therapeutic R.:
2.79 - 11.16 umol/L * 0.179211 = mg/L
1078
MYOGLOBIN, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
< 6.27 nmol/L * 17.5439 = ng/mL
Review:
09/04/2013
1217
METHYL MALONIC ACID, SERUM
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:13
Sample:
1 mL Serum (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Reference V.:
< 0.50 umol/L
Review:
17/01/2011
1272
MERCURY, BLOOD
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:6
Sample:
1 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Use metal-free container.
BLV:

End of work week (Elemental mercury and inorganic compounds) < 49.90 nmol/L * 0.200401 = ug/L
Reference V.:

Unexposed personnel < 49.90 nmol/L * 0.200401 = ug/L
1273
MANGANESE, BLOOD
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
1 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Do not use heparin sodium as an anticoagulant.
Use metal-free container.
Reference V.:
< 364.00 nmol/L / 18.2 = ug/L
1274
MANGANESE, SERUM
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Use metal-free container.
Reference V.:
< 56.42 nmol/L * 18.2 = ug/L
1285
MAGNESIUM, ERYTHROCYTES
Method:
Atomic absorption Spectrometry (Flame ifurnace).
Mounting:
Delivery period:3
Sample:
1 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)
Sample extraction:
Metal-free tubes (special for the determination of oligoelements) must be used.
Reference V.:
1.65 - 2.65 mmol/L * 2 = mEq/L
Review:
27/05/2005
1292
METHOTREXATE, SERUM
Method:
Polarized Immunofluorescense.
Mounting:
Delivery period:1
Sample:
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Toxic C.:

1-2 weeks after high-dose therapy > 0.02 umol/L
24 h after high-dose therapy > 5.00 umol/L
48 h after high-dose therapy > 0.50 umol/L
72 h after high-dose therapy > 0.05 umol/L
1350
MOG NEURONAL ANTIBODIES, CSF and SERUM
Method:
Imunocitochemistry (Cell Based Assay) .
Mounting:
Delivery period:21
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Negative
1374
MYELIN ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:10
Sample:
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/5 Titulo
Negative:
< 1/5 Titulo
1504
MITOCHONDRIAL ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/40 Titulo
Negative:
< 1/40 Titulo
Review:
26/06/2013
1538
MICROSOMAL (TPO) ANTIBODIES, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 60.00 UI/mL
Review:
09/04/2013
1636
MITOCHONDRIAL M2 ANTIBODIES, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:10
Sample:
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
1645
MYCOBACTERIA (ANTIGEN A-60) ANTIBODIES, IgG, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 125.00 - 225.00 U/mL
Positive:
> 225.00 U/mL
Negative:
< 125.00 U/mL
1646
MYCOBACTERIA (ANTIGEN A-60) ANTIBODIES, IgM, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 0.90 - 1.10 Indice
Positive:
> 1.10 Indice
Negative:
< 0.90 Indice
1733
MIELIN ASSOCIATED GLICOPROTEÍN (MAG) IgM ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:10
Sample:
0.5 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/5 Titulo
Negative:
< 1/5 Titulo
Review:
09/07/2013
1742
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX, MUSCLE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:125
Sample:
0.1 g Muscle biopsy RPMI media (-8 ºC - Freeze)
Request form:
Clinical information required.
It´s necessary the birth date.
It´s necessary to contact previously with the laboratory for study programmation..
Reference V.:
25.00 - 54.00 nmol/minxmg Prt
0.27 - 0.45 U / U CS
0.50 - 0.93 U / U CS
0.16 - 0.31 U / U CS
103.00 - 207.00 nmol/minxmg Prt
0.15 - 0.27 U / UCS
0.52 - 1.04 U / U CS
27.00 - 48.00 nmol/minxmg Prt
0.07 - 0.18 U / U CS
18.00 - 37.00 nmol/minxmg Prt
78.00 - 186.00 nmol/minxmg Prt
127.00 - 222.00 nmol/minxmg Prt
37.00 - 82.00 nmol/minxmg Prt
1751
MUCOPOLYSACCHARIDES TIPIFICATION, URINE
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:45
Sample:
25 mL Urine (-8 ºC - Freeze)
Request form:
Clinical information required.
It´s necessary the birth date.
Reference V.:
Reported for each case
Reported for each case
Reported for each case
Reported for each case
Reported for each case
1801
MI-2 ANTIBODIES, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:5
Sample:
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
1806
MYCOPLASMA PNEUMONIAE DNA, FLUIDS/EXUDATE
Method:
Real Time PCR.
Mounting:
Delivery period:11
Sample:
1 mL BAL (2-8 ºC - Refrigerate)
Alt. 1 mL Throat exudate (2-8 ºC - Refrigerate)
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Negative
Review:
01/04/2015
1834
METHYLETHYLKETONE, URINE
Method:
Gas Chromatography - Flame ionization.
Mounting:
Delivery period:9
Sample:
5 mL Urine (2-8 ºC - Refrigerate)
BLV:

End of workday (Methylethylacetone) < 27.73 umol/L * 13.867 = mg/L
1842
MUCOPOLYSACCHARIDES (SCREENING), URINE
Method:
Turbidimetry.
Mounting:
Delivery period:21
Sample:
10 mL Urine (-8 ºC - Freeze)
Request form:
Clinical information required.
Sample extraction:
First voided morning urine specimen.
Reference V.:
Both 0 6 Months 7.10 - 18.00 mg/mmol crea
Both 1 2 Years 1.90 - 6.70 mg/mmol crea
Both 11 15 Years 0.50 - 3.10 mg/mmol crea
Both 16 18 Years 0.10 - 2.10 mg/mmol crea
Both 3 6 Years 1.70 - 5.40 mg/mmol crea
Both 7 10 Years 1.00 - 4.30 mg/mmol crea
Both 7 11 Months 3.30 - 7.30 mg/mmol crea
Review:
20/02/2014
1888
METHYL IMIDAZOLE ACETIC ACID, URINE
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:24
Sample:
10 mL 24h urine (aliquot) Hydrochloric acid concentrated (37%). (2-8 ºC - Refrigerate)
Request form:
Diuresis required
Reference V.:
Excrecion:
< 4.50 mg/24h
Review:
05/03/2004
1944
METHADONE (SCREENING), URINE
Method:
Gas Chromatography - Nitrogen-Phosphorus Detector.
Mounting:
Delivery period:5
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
Discriminant V.:
0.30 ug/mL
Reference V.:
Negative
Review:
05/03/2004
1948
METHANOL, URINE
Method:
Gas Chromatography - Flame ionization.
Mounting:
Delivery period:9
Sample:
5 mL Urine (2-8 ºC - Refrigerate)
BLV:

End of workday (Methanol) < 0.47 mmol/L * 32.0513 = mg/L
Review:
05/03/2004
1962
MHPG (3 METHOXY 4 HYDROXYPHENYLGLYCOL), URINE
Method:
High efficiency liquid chromatography - Electrochemical.
Mounting:
Delivery period:14
Sample:
10 mL 24h urine (aliquot) Hydrochloric acid concentrated (37%). (2-8 ºC - Refrigerate) pH=3
Request form:
Diuresis required
Reference V.:
4.90 - 19.00 umol/24h * 0.184162 = mg/24h
Review:
04/12/2009
1976
MAGNESIUM, URINE
Method:
Atomic absorption Spectrometry (Flame ifurnace).
Mounting:
Delivery period:3
Sample:
5 mL 24h urine (aliquot) Nitric Acid (2-8 ºC - Refrigerate) pH=1
Request form:
Diuresis required
Sample extraction:
No preservatives.
Centrifuge.
Use metal-free container.
In the case of oral anticoagulants, until prothrombin values are normal.
Reference V.:
3.00 - 5.00 mmol/24h * 24.3 = mg/24h
Review:
27/05/2005
1977
MANGANESE, URINE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
BEI:

Exposed personnel (Manganese) < 728.00 nmol/g creat. * 0.054945 = ug/g creat.
Reference V.:

Unexposed personnel < 54.60 nmol/g creat. * 0.054945 = ug/g creat.
Review:
23/11/2010
1986
MELANINA, URINE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:4
Sample:
1 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
Negative
2030
MICROALBUMIN EXCRETION, URINE
Method:
Immunoturbidimetry.
Mounting:
Delivery period:1
Sample:
10 mL 24h urine (aliquot) (2-8 ºC - Refrigerate)
Reference V.:
Concentración:
< 20.00 mg/L * 0.001 = g/L
Excreción:
< 30.00 mg/24 h
Review:
09/04/2013
2031
MYOGLOBIN, URINE
Method:
Immunoturbidimetry.
Mounting:
Delivery period:2
Sample:
1 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
< 0.17 nmol/L * 0.057 = ng/mL
2111
MACROPROLACTIN, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:2
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Alt. 2 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
24/04/2007
2117
MYELIN BASIC PROTEIN, CSF
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:22
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
<= to 4.00 ng/mL
2150
MAGNESIUM, SEMINAL PLASMA
Method:
Atomic absorption Spectrometry (Flame ifurnace).
Mounting:
Delivery period:3
Sample:
1 mL Seminal plasma (2-8 ºC - Refrigerate)
Sample extraction:
Obtain semen specimen by masturbation.
Not valid if nocturnal emission has occurred.
Collect entire ejaculation in jar.
Reference V.:
> 2.88 mmol/L * 24.305 = ug/mL
Review:
27/05/2005
2165
METHYLPHENIDATE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:9
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Therapeutic R.:
8.00 - 30.00 ug/L
Review:
05/03/2004
2211
MYCOPHENOLATE MOFETIL, PLASMA
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:10
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Serum (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Therapeutic R.:
2.50 - 4.00 mg/L
Review:
04/07/2012
2386
MERCURY, URINE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:6
Sample:
10 mL Urine Nitric Acid (2-8 ºC - Refrigerate) pH<2
Alt. 10 mL 24h urine (aliquot) Nitric Acid (2-8 ºC - Refrigerate) pH<2
Sample extraction:
Before workday.
For unexposed personnel:
24-hour urine specimen; diuresis required.
BLV:
Cociente:

Before workday. (Elemental mercury and inorganic compounds) < 149.70 nmol/g crea. * 0.200401 = ug/g crea.
Lethal C.:
Concentración:
> 4000.00 nmol/L * 0.200401 = ug/L
Reference V.:

Unexposed personnel < 99.80 nmol/L * 0.200401 = ug/L
Toxic C.:

> 750.00 nmol/L * 0.200401 = ug/L
Review:
30/05/2013
2411
METHYL HIPPURIC ACID, URINE
Method:
High efficiency liquid chromatography - Ultraviolet.
Mounting:
Delivery period:7
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
BLV:

End of workday (Xylene) < 5263.16 umol/g.creat * 0.00019 = g/g.creat
Review:
26/05/2014
2479
MANTOUX INTRADERMAL REACTION 2 UT
Method:
Intradermoreaction.
Mounting:
Delivery period:1
Sample:
1 Sample/s Patient (2-8 ºC - Refrigerate)
Interpretation:
Positive: > 5.00 mm
Negative:
< 5.00 mm
BCG Positive:
> 14.00 mm
2483
MYOTONIC DYSTROPHY TYPE 1 (DM1) (DMPK GENE), BLOOD
Method:
PCR-Fragment length analysis+TP PCR.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
17/05/2013
2489
MTHFR GENE (C677T MUTATION), BLOOD
Method:
Real Time PCR.
Mounting:
Delivery period:11
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
25/02/2010
2509
MTHFR GENE (A1298C MUTATION), BLOOD
Method:
Real Time PCR.
Mounting:
Delivery period:16
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
22/04/2010
2669
MYELOID PROGENITOR CELLS, BLOOD
Method:
In vitro culture.
Mounting:
Delivery period:31
Sample:
20 mL Total blood Heparin lithium (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Resultado con EPO:
5.50 - 19.50 2x10Exp5 cel.
Resultado con FEC:
3.00 - 57.00 2x10Exp5 cel.
Resultado con MCL:
< 0.70 2x10Exp5 cel.
2803
MANDELIC / PHENYL GLIOXYLIC ACIDS, URINE
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:7
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
Sample extraction:
End of workday.
BLV:
Mandelico+Fenilglioxilico:

End of work week (Ethylbenzene) < 700.00 mg/g.creat.
End of workday (Styrene) < 400.00 mg/g.creat.
Review:
26/09/2011
2821
MYCOBACTERIUM ATIPICAL DNA, BIOPSY
Method:
Real Time PCR.
Mounting:
Delivery period:25
Sample:
1 piece/s Biopsy RPMI media (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Reference V.:
Negative
Review:
11/03/2015
2831
MANDELIC / PHENYL GLIOXYLIC ACIDS, URINE INICIO
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:9
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
Not available
Review:
02/08/2011
2986
MOLYBDENUM, SERUM
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Metal-free tubes (special for the determination of oligoelements) must be used.
Reference V.:
1.04 - 32.31 nmol/L * 0.09594 = ug/L
Review:
12/10/2010
5033
MAMMARY CYTOLOGY
Method:
Papanicolaou smear / Microscopic observation.
Mounting:
Delivery period:5
Sample:
1 mL Mammary secretion (12-20 ºC - Ambient Temp.)
Sample extraction:
Fixation with Cytospray.
R.Values:
Reported for each case.
Review:
30/05/2008
5279
MICROPHOTOGRAPHY, BIOPSY
Method:
Photomicrograph.
Mounting:
Delivery period:14
Sample:
1 piece/s Biopsy Formaldehyde buffer (10%) (12-20 ºC - Ambient Temp.)
Reference V.:
Reported for each case
6084
MAGNESIUM, DRINKING WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:10
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
6108
MONOCHLORAMINE, DIALYSATE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:2
Sample:
200 mL Dialysis water (Recipient, plastic)
UNE 111-301-90:
< 0.10 mg NH2Cl/L
Review:
09/05/2008
6115
MAGNESIUM, DIALYSATE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
UNE 111-301-90:
< 4.00 mg/L
Review:
10/06/2009
6206
MERCURY, DIALYSATE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
50 mL Dialysis water (Recipient, plastic) (pH<2 Nitric Acid)
UNE 111-301-90:
< 0.0002 mg/L
Review:
14/05/2011
6213
MANGANESE, DIALYSIS WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Ph. Eur. (1997):
< 0.10 mg/l
Review:
10/06/2009
6216
MANGANESE, DRINKING WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
RD 140/2003:
< 50.00 ug/L
6222
MERCURY, DRINKING WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
RD 140/2003:
< 1.00 ug/L
6305
MICROCYSTINE, DRINKING WATER
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:10
Sample:
1000 mL Water (Recipient, plastic)
RD 140/2003:
< 1.00 ug/L
6311
MATERIAL IN SUSPENSION, WASTE WATER
Method:
Gravimetry
Mounting:
Delivery period:6
Sample:
200 mL Water (Recipient, plastic)
DC 130/2003:
< 750.00 mg/L
RD 849/1986:
Type I spill.: 150.01 - 300.00 mg/L
Type II spill.:
80.01 - 150.00 mg/L
Type III spill.:
<= to 80.00 mg/L
Review:
09/05/2008
6320
MOLYBDENUM, WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<1 Hydrochloric Ac.)
Parametric V.:
Not established.
6674
MONOCHLORAMINE, WATER
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
100 mL Dialysis water (Recipient, plastic)
Parametric V.:
Not established.
6675
MERCURY, WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
6676
MERCURY, WASTE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
DC 130/2003:
< 0.10 mg/L
RD 849/1986:
Type I spill.: 0.06 - 0.10 mg/L
Type III spill.:
<= to 0.05 mg/L
6679
MANGANESE, WASTE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
DC 130/2003:
< 2.00 mg/L
RD 849/1986:
Type II spill.: 2.01 - 3.00 mg/L
Type I spill.:
3.01 - 10.00 mg/L
Type III spill.:
<= to 2.00 mg/L
6750
MAGNESIUM, SWIMMING POOL WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
6751
MANGANESE, SWIMMING POOL WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
6752
MERCURY, SWIMMING POOL WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
6759
MOLYBDENUM, WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<1 Hydrochloric Ac.)
Parametric V.:
Not established.
6762
MOLYBDENUM, DIALYSATE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Dialysis water (Recipient, plastic) (pH<1 Hydrochloric Ac.)
Parametric V.:
Not established.
6766
MOLYBDENUM, DRINKING WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<1 Hydrochloric Ac.)
Parametric V.:
Not established.
6771
MANGANESE, WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
6774
MAGNESIUM, WASTE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
6775
MOLYBDENUM, WASTE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<1 Hydrochloric Ac.)
Parametric V.:
Not established.
6803
MATERIAL IN SUSPENSION, WATER
Method:
Gravimetry
Mounting:
Delivery period:6
Sample:
200 mL Water (Recipient, plastic)
Reference V.:
Not established.
Review:
27/06/2009
6817
MAGNESIUM, WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) ( Nitric Acid)
Parametric V.:
Not established.
7023
MYCOPLASMA UROGENITAL, SERUM
Method:
Metabolism inhibition.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Ureaplasma Ureolitico:
Positive: >= to 1/2 Titulo
Negative:
< 1/2 Titulo
Mycoplasma Hominis:
Positive: >= to 1/2 Titulo
Negative:
< 1/2 Titulo
7024
MYCOPLASMA UROGENITAL, CULTURE
Method:
Culture broth selective for a panel of specific tests
Mounting:
Delivery period:2
Sample:
1 Smear Urethral exudate MT (Amies or Stuart) (12-20 ºC - Ambient Temp.)
1 Smear Vaginal exudate MT (Amies or Stuart) (12-20 ºC - Ambient Temp.)
25 mL Urine (12-20 ºC - Ambient Temp.)
1 mL Semen (12-20 ºC - Ambient Temp.)
Sample extraction:
See general instructions.
Only urine from male subjects can be used to culture urogenital mycoplasms.
Reference V.:
Reported for each case
Review:
01/04/2005
7097
MYCOBACTERIUM STUDY (LIQUID MEDIUM), CULTURE
Method:
Liquid culture. Identification by PCR.
Mounting:
Delivery period:45
Sample:
1 mL Pleural fluid (2-8 ºC - Refrigerate)
Alt. 1 mL Sputum/phlegm (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
Review:
02/03/2015
7412
MYCOBACTERIUM SPP. SPUTUM
Method:
Liquid culture. Identification by PCR.
Mounting:
Delivery period:45
Sample:
1 mL Sputum/phlegm (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
7600
MICROBIOLOGICAL CONTROL OF SURFACE, SURFACE
Method:
Bacteriologic culture in specific media.
Mounting:
Delivery period:13
Sample extraction:
See general instructions.
Request form:
Extraction date is required.
Sample extraction:
- Insert the cotton swab into the thinner flask and break the stick so that only the swab remains in the bottle.
- Wipe the second dry cotton swab in the same area selected with the first swab.
- Insert the second swab in the flask from the same way as before.
Transport:
The plates, once collected, will be sealed around with "Parafilm" to avoid the ball caps and possible accidental contamination, and must be transported refrigerated (2-4 º C) and protected from light. Similarly the swabs were sent. In addition, they shall be entered in the date and time of sampling.
Request form:
The type of specimen sent is required.
Sample extraction:
Prior sampling considerations
-------------------------------------------
In the environment and in the hands of technicians responsible for sampling, saprophytic microorganisms are present and that may lead to a misinterpretation of cultures due to improper handling of instruments. Hence the importance of using maximum measures of asepsis as well as an established order for sampling, avoiding as much as possible, the accidental contamination of the plates and mistakes in labeling the place where the sample has been obtained.
For all this, it is important to consider the following steps:


- Hand washing and use of sterile gloves.
- Form for data collection; label the plates with the appropriate culture medium and following the pre-established.
- After each sample, seal the used material for the sampling to avoid contamination in situ.

Sampling
---------------------------

The samples shall be implemented before the start of the surgical activity and upon completion of the hygiene of the area to study, with the least possible number of people present, without opening doors or moving any object while performing the sampling.
The culture media to be used will depend on the sample surface:
in accessible areas are pressing contact plates placed on the surface and hold still, and as evenly as possible during the contact.
In cases of irregular surfaces or difficult access to the contact plates, sterile cotton swabs must be used, and proceed as follows:

- Moisten the cotton swab with liquid transport media.
- Rub cotton swab doing lines together and side to side of the turunda.
- Insert the swab into the diluent's flask and break the stick so that only the swab remains in the bottle.
- Wipe the same area selected with the second swab dry.
- Insert the swab into the same flask and break the stick so that only the swab remains in the bottle.
In cases of flat or regular surfaces proceed the following way:

- Select an area of 100cm² for sampling with the assistance of a template.
- Humidify the cotton swab with the liquid media transport.
- Pressure the template firmly and moving it horizontally and then side to side.
R.Values:
For this reason the choice of the culture medium will also be conditioned and will be studied for each particular case.
Quantitative interpretation of data varies depending on the studied surface. But generally, for bacteria recounts:
a very clean environment would be less than 25UFC/cm ², and an acceptable environment would be less than 50 CFU / cm ².
Results Interpretation
-------------------------------------------
From the sample can be obtained quantitative data, the number of microorganisms present in a specific surface area (for smooth surfaces or flat:
UFC / cm ², for uneven surfaces: UFC / area sampled). And qualitative data, being the different species of microorganisms that have been collected in the study sample.

The detection limits of microorganisms and the type of pathogen to study, go on the basis of epidemiological data and / or health on the pollutants expected to be encountered in an environment (surfaces in an operating room in a specific location, etc.) But in most cases is not possible prior identification of the microorganism, so it is not ruling out the simultaneous use of both systems (contact plate and swab) to ensure a complete collection of all possible microorganisms.
8044
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A (RET GENE: EXONS 10 and 11), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
23/06/2004
8072
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 (MEN1 GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Umbilical cord blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
17/05/2013
8082
MIOSITIS PROFILE (IMMUNOBLOT), SERUM
Method:
Immunoblot.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
8099
MYCOBACTERIUM ATIPICAL DNA, BIOLOGIC FLUID/SPUTUM
Method:
Polymerase chain reaction.
Mounting:
Delivery period:30
Sample:
1 mL Pleural fluid (2-8 ºC - Refrigerate)
Alt. 1 mL Sputum/phlegm (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Reference V.:
Negative
Review:
09/02/2015
8120
M. TUBERCULOSIS (INTERFERON GAMMA), BLOOD
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:5
Sample:
1 mL Plasma QuantiFERON (MITOGEN) (2-8 ºC - Refrigerate)
1 mL Plasma QuantiFERON (NIL) (2-8 ºC - Refrigerate)
1 mL Plasma QuantiFERON (TB ANTIGEN) (2-8 ºC - Refrigerate)
Sample extraction:
Use the tubes supplied by this laboratory.
Samples must come to our laboratory from Monday to Thursday. Wednesday is the last possible day for blood collection.
Reference V.:
Negative
Review:
21/06/2013
8215
MICROALBUMIN/CREATININE, URINE
Method:
Immunoturbidimetry.
Mounting:
Delivery period:1
Sample:
1 mL Urine (2-8 ºC - Refrigerate)
Sample extraction:
Second voided urine specimen.
Reference V.:
Cociente:
< 2.26 g/mol crea * 8.85 = mg/g crea
Concentración:
< 20.00 mg/L * 0.001 = g/L
Review:
09/04/2013
8237
MELATONIN, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:19
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Transport:
Protect from light.
Reference V.:

Daytime <= to 30.00 pg/mL
Nighttime <= to 150.00 pg/mL
Review:
07/03/2006
8245
MYOTONIC DYSTROPHY TYPE 1 (DM1) (DMPK GENE), AMNIOTIC FLUID
Method:
PCR-Fragment length analysis+TP PCR.
Mounting:
Delivery period:30
Sample:
5 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
06/04/2006
8311
MOLECULAR VIROLOGY STUDY OF RESPIRATORY TRACT, BODY FLUID
Method:
Polymerase chain reaction.
Mounting:
Delivery period:10
Sample:
Alt. 5 mL Nasopharyngeal aspiration (-8 ºC - Freeze)
2 mL Nasopharingeous smear Vircell ® (2-8 ºC - Refrigerate)
Sample extraction:
Freeze specimen if more than 24 h passed since extraction.
Do not use swabs with wooden rod, swabs or calcium alginate gel transport.
Reference V.:
ADN Coronavirus:
Negative
ADN Enterovirus:
Negative
ARN Rinovirus:
Negative
ADN Parainfluenza 1:
Negative
ADN Parainfluenza 2:
Negative
ADN Parainfluenza 3:
Negative
ADN Parainfluenza 4:
Negative
Negative
Negative
Negative
Negative
8320
MEVALONIC ACID, URINE
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:20
Sample:
10 mL Urine (-8 ºC - Freeze)
Reference V.:
< 1.30 mmol/mol creat.
Review:
27/03/2012
8381
MYELOID PROGENITOR CELLS, BONE MARROW
Method:
In vitro culture.
Mounting:
Delivery period:31
Sample:
1 mL Bone marrow Heparin lithium (12-20 ºC - Ambient Temp.)
Reference V.:
CFU-E with Epo:
177.00 - 327.00 2x10Exp5 cel.
BFU-E with Epo:
102.00 - 186.00 2x10Exp5 cel.
Number of aggregates with FEC:
35.00 - 193.00 2x10Exp5 cel.
Number of colonies with FEC:
77.00 - 173.00 2x10Exp5 cel.
CFU-Meg with MCL:
28.30 - 46.50 2x10Exp5 cel.
8405
MYCOPLASMA PNEUMONIAE ANTIBODIES, IgM, CSF
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:15
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative: <= to 20.00 Uarb/mL
8406
MYCOPLASMA PNEUMONIAE ANTIBODIES, IgG, CSF
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative: <= to 20.00 Uarb/mL
8487
MGT-30 (TITIN) ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Is not detected
8555
MARFAN SYNDROME (FBN1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:40
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
8630
MYCOBACTERIUM TUBERCULOSIS DNA, BIOPSY
Method:
Real Time PCR.
Mounting:
Delivery period:10
Sample:
1 Sample/s Biopsy (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
11/02/2014
8670
MELANOMA CUTANEOUS MALIGNANT 2 (CDKN2A GENE: SEQUENCING), BLOOD
8724
MA1 ANTIBODIES, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:15
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
8812
METABOLISM ESTROGENS, URINE
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:16
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
Reference V.:

Ovulatory peak Females 4.00 - 43.40 ng/mg Creat
Females 4.70 - 25.70 ng/mg Creat
Postmenopause Females 3.50 - 7.50 ng/mg Creat
Luteal phase Females 7.90 - 28.50 ng/mg Creat
Postmenopause with HTS Females 3.40 - 21.20 ng/mg Creat
Females > 2.00
Postmenopause with HTS Females 0.30 - 76.10 ng/mg Creat
Folicular phase Females 3.40 - 22.80 ng/mg Creat
Females 1.30 - 18.20 ng/mg Creat
Postmenopause Females 2.00 - 5.80 ng/mg Creat
Luteal phase Females 4.60 - 24.20 ng/mg Creat
Review:
12/09/2013
8834
METHYLMALONIC ACID, URINE
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:23
Sample:
10 mL Urine (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Reference V.:
Methylmalonic Acid /crea:
5.00 - 32.00 umol/g creat.
8840
MAPROTILINE AND NORMAPROTILINE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
Maprotiline + Normaprotiline:
100.00 - 400.00 ug/L * 3.6045 = nmol/L
8855
METHYLPHENIDATE AND RITALINIC ACID, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:9
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
Methylphenidate:
8.00 - 30.00 ug/L
Ritalinic Acid:
80.00 - 300.00 ug/L
8856
MUCOPOLYSACCHARIDES (SCREENING), URINE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:21
Sample:
10 mL Urine (-8 ºC - Freeze)
Request form:
Clinical information required.
Sample extraction:
First voided morning urine specimen.
Reference V.:
Both 0 6 Months 7.10 - 18.00 mg/mmol crea
Both 1 2 Years 1.90 - 6.70 mg/mmol crea
Both 11 15 Years 0.50 - 3.10 mg/mmol crea
Both 16 18 Years 0.10 - 2.10 mg/mmol crea
Both 3 6 Years 1.70 - 5.40 mg/mmol crea
Both 7 10 Years 1.00 - 4.30 mg/mmol crea
Both 7 11 Months 3.30 - 7.30 mg/mmol crea
GLYCOSAMINOGLYCANS/L:
Not established.
8903
MILLER-DIEKER SYNDROME (17p13.3 Del: FISH), BLOOD
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:10
Sample:
5 mL Total blood Sodium heparin (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not use EDTA as an anticoagulant.
Reference V.:
Reported for each case
Review:
26/10/2010
9202
MACROAMYLASE, SERUM
Method:
Polyethylene Glycol Precipitation
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
10011
METFORMINE, SERUM
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:15
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Therapeutic R.:

0,5 - 2,5 g/day 0.16 - 1.00 mg/L
10026
MULTIMERES OF FACTOR VON WILLEBRAND, PLASMA
Method:
Agarose gel electrophoresis.
Mounting:
Delivery period:42
Sample:
2 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Reference V.:
Reported for each case
Review:
04/06/2012
10032
METHANOL, BLOOD
Method:
Gas Chromatography - Flame ionization.
Mounting:
Delivery period:9
Sample:
2.1 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 2.1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 0.05 mmol/L * 32.0513 = mg/L
Review:
23/09/2010
10060
MILLER-DIEKER SYNDROME (Del 17p13.3: FISH), AMNIOTIC FLUID
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:15
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
10203
MIRTAZAPINE, SERUM
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:10
Sample:
2 mL Serum (-8 ºC - Freeze)
Therapeutic R.:
30.00 - 80.00 ug/L
10210
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A (RET GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
29/07/2011
10245
MIANSERIN, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:15
Sample:
2 mL Serum (-8 ºC - Freeze)
Therapeutic R.:
30.00 - 120.00 ng/mL
10247
MYCOPLASMA PNEUMONIAE DNA, BIOPSY
Method:
Real Time PCR.
Mounting:
Delivery period:11
Sample:
1 piece/s Biopsy (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
06/03/2012
10257
METHADONE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:7
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Therapeutic R.:
50.00 - 1000.00 ng/mL
80.00 - 200.00 ng/mL
Toxic C.:
> 1000.00 ng/mL
> 500.00 ng/mL
10291
METHYLPHENIDATE, URINE
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:7
Sample:
5 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
Negative
10375
METHYLCROTONYL-CoA CARBOXYLASE, FIBROBLASTES
Mounting:
Delivery period:105
Sample:
1 piece/s Skin Biopsy RPMI media (12-20 ºC - Ambient Temp.)
Sample extraction:
Analysis with special requirements. You should contact the laboratory before extraction and shipment of the sample.
Reference V.:
Reported for each case
10699
MIOCLONIC DYSTONIA (SGCE GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification).
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10700
MIOCLONIC DYSTONIA (SGCE GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10704
MYOTONIC DYSTROPHY TYPE 2 (DM2) (ZNF9 GENE), BLOOD
Method:
TP-PCR.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
17/05/2013
10775
MUCOPOLYSACCHARIDOSIS IH (IDUA GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
14/09/2012
10776
MUCOPOLYSACCHARIDOSIS IH (IDUA GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10795
MARFAN SYNDROME (FBN1 AND TGFBR2 GENES: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:45
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10796
MARFAN SYNDROME (FBN1 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
10 mL Total blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
02/10/2012
10800
McARDLE DISEASE (PYGM GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10801
McARDLE DISEASE (PYGM GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10804
MELAS SYNDROME, BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
05/05/2014
10871
MUCOPOLYSACCHARIDOSIS TYPE IIIA (SGSH GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10872
MUCOPOLYSACCHARIDOSIS TYPE IIIA (SGSH GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10873
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B (RET GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10904
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B (RET GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10936
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 (MEN1 GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10938
MULTIPLE ENDROCRINE NEOPLASIA TYPE 1 (MEN1 GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
03/05/2014
10990
MYOTONIC DYSTROPHY TYPE 1 (DM1) (DMPK GENE), CHORIONIC VILLI
Method:
PCR-Fragment length analysis+TP PCR.
Mounting:
Delivery period:30
Sample:
0.01 g Corial villus (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
10991
MUSCULAR DYSTROPHY MEROSIN-DEFICIENT (LAMA2 GENE), C. VILLI
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
0.01 g Corial villus (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
11008
MUCOPOLYSACCHARIDOSIS TYPE I (IDUA GENE), AMNIOTIC FLUID
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
11013
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A (RET GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11015
MUCOPOLYSACCHARIDOSIS TYPE IIIB (NAGLU GENE), AMNIOTIC FLUID
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
11058
MUCOPOLYSACCHARIDOSIS TYPE IIIB (NAGLU GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11091
MALIGNANT HYPERTHERMIA (RYR1 GENE: NGS), BLOOD
Method:
Next Generation Sequencing (NGS).
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11105
MILROY DISEASE (FLT4 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11139
MUSCULAR DYSTROPHY MEROSIN-DEFICIENT (LAMA2 GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11168
MYCN GENE (2p24.3), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:21
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11192
METHYLCROTONYLGLYCINURIA TYPE II (MCC2 GENE: SEC.), FIBROBLASTS
Method:
Next Generation Sequencing (NGS)
Mounting:
Delivery period:110
Sample:
1 piece/s Skin Biopsy RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Analysis with special requirements. You should contact the laboratory before extraction and shipment of the sample.
Reference V.:
Reported for each case
Review:
03/09/2012
11193
METHYLCROTONYLGLYCINURIA TYPE I (MCCC1 GENE: SEC.), FIBROBLASTS
Method:
Next Generation Sequencing (NGS)
Mounting:
Delivery period:110
Sample:
1 piece/s Skin Biopsy RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Analysis with special requirements. You should contact the laboratory before extraction and shipment of the sample.
Reference V.:
Reported for each case
Review:
03/09/2012
11206
METHYLCROTONYLGLYCINURIA TYPE I (MCCC1 GENE: MLPA), FIBROBLASTS
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:65
Sample:
1 piece/s Skin Biopsy Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Analysis with special requirements. You should contact the laboratory before extraction and shipment of the sample.
Reference V.:
Reported for each case
11227
M3 MITOCHONDRIAL ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/40 Titulo
Negative:
< 1/40 Titulo
11228
M4 MITOCHONDRIAL ANTIBODIES, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Negative
11229
M5 MITOCHONDRIAL ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/40 Titulo
Negative:
< 1/40 Titulo
11230
M9 MITOCHONDRIAL ANTIBODIES, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Negative
11410
MITOTANE, SERUM
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:8
Sample:
3 mL Serum (-8 ºC - Freeze)
Therapeutic R.:
10.00 - 20.00 mg/L
Review:
24/09/2012
11560
MELATONIN, SALIVA
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:15
Sample:
1 mL Saliva (2-8 ºC - Refrigerate)
Reference V.:

Daytime < 5.00 pg/mL
Nighttime > 10.00 pg/mL
Review:
30/10/2012
11606
MYCOPLASMA HOMINIS DNA, URETHRAL EXUDATE
Method:
Real Time PCR.
Mounting:
Delivery period:8
Sample:
1 mL Urethral exudate (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
30/10/2013
11645
MIELINE ASSOCIATED GLICOPROTEIN (MAG) IgM ANTIBODIES, CSF
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:10
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/5 Titulo
Negative:
< 1/5 Titulo
Review:
23/06/2013
11650
MA1 ANTIBODIES, CSF
Method:
Immunoblot.
Mounting:
Delivery period:15
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
11765
MOLYBDENUM, BLOOD
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:10
Sample:
7.5 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)
Sample extraction:
Use metal-free container.
Reference V.:
8.03 - 81.96 nmol/L * 0.09594 = ug/L
11816
MITOCHONDRIAL DEAFNESS (MTRNR1 GENE: KNOWN MUTATION), BLOOD
11873
M2-PIRUVATE KINASE, PLASMA
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Reference V.:
0.00 - 15.00 U/mL
11946
mGluR1 NEURONAL ANTIBODIES, CSF
Method:
Immunohistochemistry
Mounting:
Delivery period:21
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
02/05/2014
11987
MYB GENE REARRANGEMENT (6q23) (FISH), BONE MARROW
Method:
Complementary DNA chain hybridization.
Mounting:
Delivery period:11
Sample:
3 mL Bone marrow Sodium heparin RPMI media (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
Reference V.:
Reported for each case
11991
MORPHINE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:6
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
In case of oral therapy, the serum sample should be obtained 3 to 5 hours after the last administration.
Therapeutic R.:
10.00 - 100.00
Review:
24/07/2014
14240
MUSK ANTIBODIES, SERUM
Method:
Radioimmunoanalysis.
Mounting:
Delivery period:11
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 0.40 U/mL
Review:
18/11/2014
14313
MGMT GENE PROMOTOR METHYLATION STUDY, PARAFFIN TISSUE
Method:
MS-PCR (Methylation specífic-PCR)
Mounting:
Delivery period:45
Request form:
Clinical information required.
Reference V.:
Reported for each case
14314
MYCOBACTERIUM spp DNA, BONE MARROW
Method:
PCR-Sequencing.
Mounting:
Delivery period:10
Sample:
2 mL Bone marrow Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
14323
MYELOPROLIFERATIVE CHRONIC SYNDROME (EXON 9 CALR GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:25
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14380
mGluR5 NEURONAL ANTIBODIES, SERUM
Method:
Immunohistochemistry
Mounting:
Delivery period:21
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
14381
MYELIN ANTIBODIES IgM, CSF
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:10
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
14392
MYOGLOBIN, URINE
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:2
Sample:
1 mL Urine (2-8 ºC - Refrigerate)
Sample extraction:
Adjust urine at pH 8 - 9 with0,1 mL of a carbonate sodic 10 % solution.
Reference V.:
<= to 1.20 nmol/L * 17.5439 = ng/mL
Review:
02/06/2015
14604
MORPHIN (SCREENING), URINE
Method:
Immunochromatography.
Mounting:
Delivery period:1
Sample:
3 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
Negative
Discriminant V.:
300.00 ug/L
14605
METAMPHETAMINES (SCREENING), URINE
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:1
Sample:
3 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
Negative
Discriminant V.:
500
14641
mGluR5 NEURONAL ANTIBODIES, CSF
Method:
Immunohistochemistry
Mounting:
Delivery period:21
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
14644
mGluR1 NEURONAL ANTIBODIES, SERUM
Method:
Immunohistochemistry
Mounting:
Delivery period:21
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
14649
MDA-5 - CADM-140 ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay + Inmunoblot.
Mounting:
Delivery period:18
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
14665
MYCOBACTERIUM spp DNA, BIOPSY
Method:
PCR-Sequencing.
Mounting:
Delivery period:15
Sample:
1 piece/s Biopsy (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
Review:
10/04/2015
14667
METAQUALONE (SCREENING), URINE
Method:
Qualitative Immunochromatographie.
Mounting:
Delivery period:6
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
Discriminant V.:
300.00 ug/L
Reference V.:
Negative
14686
METHYLCROTONYLGLYCINURIA TYPE II (MCC2 GENE: MLPA), FIBROBLASTS
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:65
Sample:
1 piece/s Skin Biopsy (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Analysis with special requirements. You should contact the laboratory before extraction and shipment of the sample.
Reference V.:
Reported for each case
14690
METHYLCROTONYLGLYCINURIE TYPE II (GÈNE MCCC2: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14691
METHYLCROTONYLGLYCINURIE TYPE I (MCCC1 GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14775
MAGNESIUM (Absorption molecular), SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Separate serum as soon as possible.
Reference V.:
Both 1 5 Years 0.70 - 0.95 mmol/L * 2.43072 = mg/dL
Both > 90 Years 0.70 - 0.95 mmol/L * 2.43072 = mg/dL
Both 5 12 Years 0.70 - 0.86 mmol/L * 2.43072 = mg/dL
Both 1 12 Months 0.65 - 0.88 mmol/L * 2.43072 = mg/dL
Both 1 30 Days 0.62 - 0.91 mmol/L * 2.43072 = mg/dL
Both 20 60 Years 0.66 - 1.07 mmol/L * 2.43072 = mg/dL
Both 12 20 Years 0.70 - 0.91 mmol/L * 2.43072 = mg/dL
Both 60 90 Years 0.66 - 0.99 mmol/L * 2.43072 = mg/dL
14777
METHADONE (CONFIRMATORY), URINE
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:10
Sample:
15 mL Urine (2-8 ºC - Refrigerate)
Discriminant V.:
0.20 ug/mL
Reference V.:
Negative
14916
MULTIPLE ENDOCRINE NEO 2 (RET GENE: EXONS 10,11,13,14,15 and 16), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:50
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15329
MYCOPLASMA PNEUMONIAE ANTIBODIES, IgG, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Please mark specimens clearly as "acute" or "convalescent."
Interpretation:
Positive: >= to 10.00 UA/mL
Negative:
< 10.00 UA/mL
R.Values:
The study of two serum specimens obtained at an interval of 14-21 days is recommended to confirm recent infection.
15330
MYCOPLASMA PNEUMONIAE ANTIBODIES, IgM, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 10.00 Indice
Positive:
>= to 10.00 Indice
15331
MEASLES VIRUS ANTIBODIES, IgG, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 13.5 - 16.5 Uarb/mL
Positive:
> 16.5 Uarb/mL
Negative:
< 13.5 Uarb/mL
15332
MEASLES VIRUS ANTIBODIES, IgM, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1.10 Indice
Negative:
< 0.90 Indice
Indeterminate:
0.90 - 1.09 Indice
15371
M. TUBERCULOSIS RESISTANCE ANTIBIOTICS FIRST LINE, CULTURE
Method:
Polymerase chain reaction.
Mounting:
Delivery period:12
Sample:
1 mL Colonies (pure culture) (12-20 ºC - Ambient Temp.)
Reference V.:
Reported for each case
15372
M. TUBERCULOSIS RESISTANCE ANTIBIOTICS SECOND LINE, CULTURE
Method:
Polymerase chain reaction.
Mounting:
Delivery period:12
Sample:
1 mL Colonies (pure culture) (12-20 ºC - Ambient Temp.)
Reference V.:
Reported for each case
15410
MYCOPLASMA HOMINIS DNA, GENITAL SMEAR
Method:
Real Time PCR.
Mounting:
Delivery period:8
Sample:
1 Sample/s Smear (2-8 ºC - Refrigerate)
Reference V.:
Negative
15448
MULTIPLE ENDOCRINE NEOPLASIA 2B 8RET GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15557
MYCOBACTERIUM TUBERCULOSIS COMPLEX ADN, SPUTUM
Method:
Real Time PCR.
Mounting:
Delivery period:11
Sample:
2 mL Sputum/phlegm (-8 ºC - Freeze)
Reference V.:
Negative
R.Values:
This study only detects the following Mycobacterium species: M. tuberculosis, M. bovis, M. africanum and M. microti.
15588
MYCOBACTERIUM TUBERCULOSIS COMPLEX ADN, PLEURAL FLUID
Method:
Real Time PCR.
Mounting:
Delivery period:11
Sample:
2 mL Pleural fluid (-8 ºC - Freeze)
Reference V.:
Negative
R.Values:
This study only detects the following Mycobacterium species: M. tuberculosis, M. bovis, M. africanum and M. microti.
15589
MYCOBACTERIUM TUBERCULOSIS COMPLEX ADN, URINE
Method:
Real Time PCR.
Mounting:
Delivery period:11
Sample:
5 mL Urine (-8 ºC - Freeze)
Reference V.:
Negative
R.Values:
This study only detects the following Mycobacterium species: M. tuberculosis, M. bovis, M. africanum and M. microti.
15590
MYCOBACTERIUM TUBERCULOSIS COMPLEX ADN, BLOOD
Method:
Real Time PCR.
Mounting:
Delivery period:11
Sample:
2 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Negative
R.Values:
This study only detects the following Mycobacterium species: M. tuberculosis, M. bovis, M. africanum and M. microti.
15596
MYNUTRIGENES, BLOOD
Mounting:
Delivery period:11
Sample:
1 Smear Buccal smear. (2-8 ºC - Refrigerate)
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
15620
MAST CELL DISEASE (C-KIT GENE: EXON 17), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15622
MYELOID ACUTE LEUKEMIA (c-KIT GENE: EXONS 8,10,11 and 17), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15665
MPO (MYELOPEROXIDASE) ANTIBODIES, SERUM
Method:
Multiplex Fluorometric ImmunoAssay
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1.00 IA
Negative:
< 1.00 IA
15710
MYCOBACTERIUM TUBERCULOSIS COMPLEX ADN, BRONCHOALVEOLAR LAVAGE
Method:
Real Time PCR.
Mounting:
Delivery period:11
Sample:
2 mL BAL (-8 ºC - Freeze)
Reference V.:
Negative
R.Values:
This study only detects the following Mycobacterium species: M. tuberculosis, M. bovis, M. africanum and M. microti.
15748
MIDAZOLAM, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:8
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
40.00 - 100.00 µg/L * 0.00307 = µmol/L
15750
MEDAZEPAM, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:8
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
100.00 - 500.00 µg/L * 0.003693 = µmol/L
15851
MYCOPLASMA GENITALUM DNA, GENITAL SMEAR
Method:
Multiplex PCR-Real Time.
Mounting:
Delivery period:4
Sample:
1 Sample/s Smear (2-8 ºC - Refrigerate)
Reference V.:
Negative
15897
METHYLCROTONYLGLICINURY TYPE II (MCCC2 GENE), AMNIOTIC FLUID
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
16103
METHOTREXATE, SERUM
Method:
Homogeneous enzyme immunoassay (EMIT).
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Toxic C.:

1-2 weeks after high-dose therapy > 0.02 umol/L
24 h after high-dose therapy > 5.00 umol/L
48 h after high-dose therapy > 0.50 umol/L
72 h after high-dose therapy > 0.05 umol/L